NEA Management Company as of Sept. 30, 2013
Portfolio Holdings for NEA Management Company
NEA Management Company holds 31 positions in its portfolio as reported in the September 2013 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Groupon Com Cl A | 24.2 | $610M | 54M | 11.21 | |
Tesaro | 15.1 | $382M | 9.9M | 38.74 | |
Cvent | 10.2 | $257M | 7.3M | 35.17 | |
Epizyme | 9.6 | $242M | 6.0M | 40.00 | |
Xoom | 6.4 | $161M | 5.1M | 31.76 | |
Clovis Oncology | 5.5 | $139M | 2.3M | 60.80 | |
Channeladvisor | 4.0 | $101M | 2.8M | 36.63 | |
Fusion-io | 3.7 | $94M | 7.0M | 13.39 | |
Supernus Pharmaceuticals (SUPN) | 3.1 | $78M | 11M | 7.33 | |
Hyperion Therapeutics | 3.0 | $75M | 2.9M | 26.13 | |
Millennial Media | 2.3 | $58M | 8.2M | 7.07 | |
Boingo Wireless | 1.5 | $38M | 5.5M | 7.00 | |
Audience | 1.3 | $32M | 2.9M | 11.24 | |
Sunesis Pharmaceuticals | 1.1 | $28M | 5.6M | 4.96 | |
Lexicon Pharmaceuticals | 1.1 | $28M | 12M | 2.38 | |
Targacept | 1.0 | $24M | 4.6M | 5.31 | |
InterMune | 0.8 | $21M | 1.3M | 15.38 | |
Nektar Therapeutics (NKTR) | 0.8 | $19M | 1.8M | 10.45 | |
Linkedin Corp Com Cl A | 0.7 | $19M | 77k | 246.05 | |
Glu Mobile | 0.7 | $17M | 5.9M | 2.78 | |
Zhone Technologies | 0.6 | $15M | 4.8M | 3.15 | |
Amicus Therapeutics (FOLD) | 0.5 | $13M | 5.7M | 2.32 | |
Cadence Pharmaceuticals | 0.5 | $13M | 2.1M | 6.30 | |
Exelixis (EXEL) | 0.5 | $13M | 2.2M | 5.82 | |
Rigel Pharmaceuticals | 0.5 | $12M | 3.2M | 3.58 | |
Alimera Sciences | 0.4 | $10M | 2.7M | 3.76 | |
Orexigen Therapeutics | 0.3 | $7.1M | 1.2M | 6.13 | |
Transcept Pharmaceuticals | 0.3 | $6.6M | 2.1M | 3.18 | |
Solta Medical | 0.2 | $5.9M | 2.9M | 2.07 | |
ArQule | 0.2 | $5.9M | 2.5M | 2.33 | |
NeuroMetrix | 0.0 | $95k | 57k | 1.66 |